Review: taking Meloxicam and Adderall 20 together


Summary

Drug interactions are reported among people who take Meloxicam and Adderall 20 together. This review analyzes the effectiveness and drug interactions between Meloxicam and Adderall 20. It is created by eHealthMe based on reports of 183 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Meloxicam and Adderall 20 >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Meloxicam

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. (latest outcomes from Meloxicam 10,177 users)

Adderall 20

Adderall 20 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 20 2,169 users)

On Jul, 25, 2016

183 people who take Meloxicam, Adderall 20 are studied.


Number of reports submitted per year:

Meloxicam and Adderall 20 drug interactions.

Drug effectiveness over time:

Meloxicam:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 52.0% - (10 of 19 people)
  • 6 - 12 months: 20.0% - (1 of 5 people)
  • 1 - 2 years: 15.0% - (2 of 13 people)
  • 2 - 5 years: 2.0% - (1 of 40 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)
Adderall 20:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 66.0% - (6 of 9 people)
  • 6 - 12 months: 38.0% - (5 of 13 people)
  • 1 - 2 years: 12.0% - (1 of 8 people)
  • 2 - 5 years: 85.0% - (46 of 54 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 33.0% - (2 of 6 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Meloxicam:
  • female: 28.0% - (14 of 49 people)
  • male: 4.0% - (2 of 41 people)
Adderall 20:
  • female: 42.0% - (23 of 54 people)
  • male: 97.0% - (40 of 41 people)

Drug effectiveness by age:

Meloxicam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 54.0% - (6 of 11 people)
  • 30-39: 33.0% - (6 of 18 people)
  • 40-49: 8.0% - (1 of 12 people)
  • 50-59: 20.0% - (2 of 10 people)
  • 60+: 0.0% - (0 of 38 people)
Adderall 20:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 75.0% - (9 of 12 people)
  • 30-39: 30.0% - (6 of 20 people)
  • 40-49: 30.0% - (4 of 13 people)
  • 50-59: 54.0% - (6 of 11 people)
  • 60+: 97.0% - (37 of 38 people)

Most common drug interactions over time *:

< 1 month:
  • neuropathy - sciatic nerve
  • pain - back
  • peripheral neuropathy
  • anxiety
  • vision blurred
  • vision problems
1 - 6 months:
  • weight gain
  • diarrhea
  • drowsiness
  • lack of coordination
  • lack of strength
  • vaginal yeast infection
  • alcohol interaction
  • crying
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fatigue
6 - 12 months:
  • fatigue
  • memory impairment
  • urinary tract infection
  • weight decreased
  • deep vein thrombosis
  • dizziness
  • injury
  • joint swelling
  • pain
  • pain in extremity
1 - 2 years:
  • chest pain aggravated
  • cyanosis central
  • deafness unilateral
  • difficulty in breathing
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • nausea and vomiting
  • neck, shoulder and arm syndrome
  • orthopnoea
  • pain in jaw
  • painful respiration
2 - 5 years:
  • injury
  • deep vein thrombosis
  • kidney infection
  • nephrolithiasis
  • pain in extremity
  • pulmonary embolism
  • depression
  • joint swelling
  • memory impairment
  • pain
5 - 10 years:
  • abdominal pain lower
  • anxiety
  • arteriosclerosis
  • brain mass
  • chest pain
  • chronic pain
  • deep vein thrombosis
  • depression
  • dizziness
  • dyspnoea
10+ years:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • acne
  • blood pressure increased
  • confusion
  • constipation
  • crowded teeth
  • diplopia
  • eye floaters
  • frequent headaches
  • herniated nucleus pulposus (slipped disk)
not specified:
  • pain
  • fatigue
  • back pain
  • drug ineffective
  • rash
  • anxiety
  • bipolar disorder
  • dizziness
  • weight decreased
  • cerebrovascular accident

Most common drug interactions by gender *:

female:
  • fatigue
  • pain
  • anxiety
  • dizziness
  • injury
  • memory impairment
  • rash
  • back pain
  • deep vein thrombosis
  • weight decreased
male:
  • myelitis transverse
  • auricular swelling
  • cluster headache
  • drug ineffective
  • flushing
  • hypoaesthesia
  • lip swelling
  • muscular weakness
  • pain in extremity
  • paraesthesia

Most common drug interactions by age *:

10-19:
  • pain
  • abdominal pain upper
  • contusion
  • fall
  • fatigue
  • headache
  • laceration
  • loss of consciousness
  • rash
  • rash pruritic
20-29:
  • injury
  • pain
  • thrombophlebitis superficial
  • anxiety
  • deep vein thrombosis
  • diarrhea
  • drowsiness
  • joint swelling
  • lack of coordination
  • lack of strength
30-39:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • nausea and vomiting
  • alcohol interaction
  • crying
  • fatigue
  • feeling jittery
  • heart rate increased
  • heat illness
  • impaired memory
  • tachycardia
40-49:
  • dyspnoea
  • pruritus
  • abnormal behaviour
  • neuropathy - sciatic nerve
  • pain - back
  • peripheral neuropathy
  • vision blurred
  • abdominal pain upper
  • acne
  • activities of daily living impaired
50-59:
  • memory impairment
  • back pain
  • fatigue
  • weight decreased
  • anxiety
  • emotional disorder
  • rash
  • urinary tract infection
  • drug ineffective
  • weight increased
60+:
  • myelitis transverse
  • arteriosclerosis
  • blood pressure increased
  • chest pain
  • confusion
  • crowded teeth
  • depression
  • diplopia
  • dizziness
  • drug ineffective

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Meloxicam and Adderall 20?

Can you answer these questions?

More questions for: Meloxicam, Adderall 20

You may be interested in these reviews

More reviews for: Meloxicam, Adderall 20

On eHealthMe, Meloxicam (meloxicam) is often used to treat arthritis. Adderall 20 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.